From Symptoms to Systems: The Rise of Multiomics in Disease Research

  In this BioPharma Boardroom interview, Jason Causon, Senior Technical Product Manager for Accurate Mass Platforms at SCIEX, explores how multiomi...

February 04, 2026 | Wednesday | Interaction
mRNA’s Next Act: Why Analytical Science Matters More Than Ever

As mRNA technologies move rapidly beyond COVID-19 into vaccines and therapies for cancer, rare diseases, and personalized medicine, scientific complexity i...

February 04, 2026 | Wednesday | Interaction
Cellares Expands Automation Platform into Gene-Edited HSC Therapies Through Stanford Medicine Collaboration

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), announced a collaboration with the Stanford Center for Definitive and C...

February 05, 2026 | Thursday | News
AGC Biologics Earns Anvisa GMP Certification to Support Global Commercialization of Customer Biologics

The Seattle facility of AGC Biologics, your friendly CDMO expert, has received a Good Manufacturing Practices Certification from Agência Nacional d...

February 05, 2026 | Thursday | News
insitro Uncovers Novel Peripheral Obesity Target Through AI-Enabled Brown Fat Genetics

AI-enabled brown adipose tissue (BAT) phenotype unlocks population-scale human genetic discovery BAT-01 knockdown drives 15% body-weight reduction in ...

February 04, 2026 | Wednesday | News
Illumina Deepens Leadership in Proteomics and Multiomics With Completed SomaLogic Acquisition

Deeply expands leadership in proteomics and multiomics Combined capabilities bring high scalability, flexibility, and affordability into protein an...

February 03, 2026 | Tuesday | News
KORU Medical Receives FDA Clearance for FreedomEDGE® Infusion System to Deliver UCB’s RYSTIGGO® in gMG

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...

February 02, 2026 | Monday | News
Origami Therapeutics and Ipsen Enter Global Collaboration to Advance Disease-Modifying Therapy for Rare Neurodegenerative Disease

- Ipsen obtains exclusive option to global license a research program for a selective disease-modifying approach to neurodegenerative diseases ...

February 02, 2026 | Monday | News
H.U. Group’s Fujirebio Launches Fully Automated pTau217 CSF Assay for Alzheimer’s Research

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automat...

January 30, 2026 | Friday | News
Tenpoint Therapeutics Raises $235M in Series B Financing and Credit Facility to Support YUVEZZI Launch

Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging...

January 30, 2026 | Friday | News
Takeda CEO Christophe Weber Says FY2025 Is “Pivotal” as Company Raises Outlook Despite VYVANSE Erosion

  Year-to-Date Revenue Declined by 2.8% at Constant Exchange Rate (CER), 3.3% atActual Exchange Rates (AER); Impact of VYVANSE® Generics is T...

February 02, 2026 | Monday | Company results
China’s NMPA Approves Almirall’s Seysara® for Moderate-to-Severe Acne

China’s National Medical Products Administration (NMPA) has approved Seysara®(sarecycline hydrochloride) for the treatment of inflammatory ...

January 30, 2026 | Friday | News
Elevar Submits NDA for Lirafugratinib as Second-Line FGFR2-Driven Cholangiocarcinoma Therapy

  Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating tre...

January 30, 2026 | Friday | News
SK Capital to Divest Noramco API Assets to Siegfried as Halo Pharma Emerges as Stand-Alone Drug Product CDMO

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) The...

January 29, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close